COMPASS Pathways CMPS
NASDAQ CMPS
$9.30 +0.05 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

COMPASS Pathways (CMPS) Interest Paid (2024)

Updated

COMPASS Pathways' Interest Paid came in at $3.05 million for FY2025, down 0.7% from $3.07 million in FY2024.

Analysis

COMPASS Pathways (CMPS) Interest Paid (2024) Analysis & Trends

  • Per Business Quant, earlier years put Interest Paid at $3.07 million in FY2024 (+144.8%) and $1.25 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 283.00 Mn
10 COMPASS Pathways 1.31 Bn -182.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 765,000.00
API Access

COMPASS Pathways Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=CMPS&period=max&api_key=YOUR_API_KEY